Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Cancer. 2023 Aug 20;129(23):3761–3771. doi: 10.1002/cncr.34980

Table 2.2:

Symptom Prevalence for LGG Group by Tumor Lobe*

Frontal (n = 155) Parietal (n = 33) Temporal (n = 60) Difference Between Lobes

Symptom No. % No. % No. % P-Value
Driving Deficit 42 30.4 11 42.3 17 33.3 p = 0.49

Seizure 18 13.0 1 3.8 11 21.2 p = 0.10

Weakness in an Arm or Leg 45 32.6 7 26.9 12 23.1 p = 0.41

Difficulty Getting Words Out 86 62.3 14 53.8 29 56.9 p = 0.63

Difficulty Remembering New Facts 87 63.5 14 53.8 36 69.2 p = 0.41

Headache 73 53.3 13 50.0 24 47.1 p = 0.74

Personality Change 53 38.4 9 34.6 18 34.6 p = 0.86

Visual Disturbance 45 32.6 11 42.3 25 49.0 p = 0.10

Decreased Sensation in Face, Arms, or Legs 108 78.3 15 57.7 39 76.5 p = 0.08

Trouble Thinking 86 62.8 14 53.8 31 59.6 p = 0.68
*

In past 7 days

Note: Sample sizes vary due to missing values.